Published in Clin Cancer Res on October 29, 2014
Examination of the Pancreas in New-onset Diabetes (EXPAND) | NCT02001337
Pancreatic Cancer Exosomes: Shedding Off for a Meaningful Journey. Pancreat Disord Ther (2016) 0.79
Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium. Diabetologia (2017) 0.76
Minireview: Emerging Roles for Extracellular Vesicles in Diabetes and Related Metabolic Disorders. Mol Endocrinol (2015) 0.76
Pancreatic cancer-associated diabetes is an "exosomopathy". Clin Cancer Res (2015) 0.76
Macropinocytosis Exploitation by Cancers and Cancer Therapeutics. Front Physiol (2016) 0.76
Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway. Sci Rep (2017) 0.75
Does diabetes mellitus affect presentation, stage and survival in operable pancreatic cancer? Hepatobiliary Surg Nutr (2016) 0.75
Immunosuppressive CD14(+)HLA-DR(lo/neg) monocytes are elevated in pancreatic cancer and "primed" by tumor-derived exosomes. Oncoimmunology (2016) 0.75
Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression. World J Gastrointest Oncol (2017) 0.75
The role of pancreatic cancer-derived exosomes in cancer progress and their potential application as biomarkers. Clin Transl Oncol (2017) 0.75
Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma. Oncogene (2017) 0.75
Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p. Mol Cancer (2017) 0.75
International network of cancer genome projects. Nature (2010) 20.35
Diagnosis and classification of diabetes mellitus. Diabetes Care (2012) 9.03
Exosomes: extracellular organelles important in intercellular communication. J Proteomics (2010) 6.47
Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov (2013) 4.35
Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun (1993) 4.32
Regulation of insulin biosynthesis in pancreatic beta cells by an endoplasmic reticulum-resident protein kinase IRE1. Cell Metab (2006) 4.11
The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes. Endocr Rev (2008) 3.56
Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology (2007) 3.20
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol (2009) 2.92
Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab (2004) 2.92
International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev (2002) 2.86
Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology (2005) 2.60
Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology (2008) 2.58
Islet amyloid and type 2 diabetes mellitus. N Engl J Med (2000) 2.07
Diabetes and pancreatic cancer. Mol Carcinog (2012) 1.71
Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg (1993) 1.62
Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg (1993) 1.57
New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev Gastroenterol Hepatol (2013) 1.54
Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer. Gastroenterology (2001) 1.35
Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice. Gastroenterology (2012) 1.34
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest (1994) 1.31
Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR. Cancer Res (2007) 1.17
cAMP-dependent phosphorylation of PTB1 promotes the expression of insulin secretory granule proteins in beta cells. Cell Metab (2006) 1.14
Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med (1994) 1.14
The pancreatic cancer cell line MIA PaCa2 produces one or more factors able to induce hyperglycemia in SCID mice. Anticancer Res (1996) 1.13
Regulation of insulin secretion and blood glucose metabolism by adrenomedullin. Endocrinology (1996) 1.12
Islets in type 2 diabetes: in honor of Dr. Robert C. Turner. Diabetes (2008) 1.11
Extracellular vesicles: communication, coercion, and conditioning. Mol Biol Cell (2013) 0.99
Beta-cell function and insulin resistance evaluated by HOMA in pancreatic cancer subjects with varying degrees of glucose intolerance. Pancreatology (2005) 0.98
DNA conjugated SWCNTs enter endothelial cells via Rac1 mediated macropinocytosis. Nano Lett (2012) 0.95
Synergistic up-regulation of Hexokinase-2, glucose transporters and angiogenic factors in pancreatic cancer cells by glucose deprivation and hypoxia. Exp Cell Res (2007) 0.94
Increased plasma adrenomedullin levels in patients with acute myocardial infarction in proportion to the clinical severity. Heart (1998) 0.93
Weight loss precedes cancer-specific symptoms in pancreatic cancer-associated diabetes mellitus. Pancreas (2011) 0.91
Study of plasma adrenomedullin level in normal pregnancy and preclampsia. Medscape J Med (2008) 0.87
Diabetes and pancreatic cancer. Minerva Gastroenterol Dietol (2012) 0.85
Integrating insulin secretion and ER stress in pancreatic β-cells. Nat Cell Biol (2012) 0.85
Characterization and effects on cAMP accumulation of adrenomedullin and calcitonin gene-related peptide (CGRP) receptors in dissociated rat spinal cord cell culture. Br J Pharmacol (2006) 0.81
Morphometric studies in human pancreatic cancer argues against the etiological role of type 2 diabetes in pancreatic cancer. Histol Histopathol (2010) 0.81
Adrenomedullin as a pancreatic hormone. Microsc Res Tech (2002) 0.78
Tumor Necrosis Factor-alpha as a Treatment Target for the Cancer Anorexia/Weight Loss Syndrome. Support Cancer Ther (2004) 0.77
Exercise-induced increase in circulating adrenomedullin is related to mean blood pressure in heart transplant recipients. J Clin Endocrinol Metab (2000) 0.77
Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer. Gastroenterology (2014) 1.78
IgG4-related skin disease. JAMA Dermatol (2013) 1.07
Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer. Cancer Discov (2015) 0.90
Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients. Cancer Epidemiol Biomarkers Prev (2015) 0.89
Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101. JAMA Surg (2016) 0.84
Associations between Environmental Exposures and Incident Colorectal Cancer by ESR2 Protein Expression Level in a Population-Based Cohort of Older Women. Cancer Epidemiol Biomarkers Prev (2015) 0.78
Inhibition of endoglin-GIPC interaction inhibits pancreatic cancer cell growth. Mol Cancer Ther (2014) 0.77
Cytotoxic T-cells and granzyme B associated with improved colorectal cancer survival in a prospective cohort of older women. Cancer Epidemiol Biomarkers Prev (2016) 0.75
Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy: A Pooled Analysis From 2 Randomized Clinical Trials. JAMA Oncol (2017) 0.75
Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials. JAMA Oncol (2017) 0.75